Strong operations and eased regulatory fears
- EHC is the largest U.S. owner and operator of inpatient rehabilitation hospitals, known as IRFs.
- Q2 2026 net operating revenue rose 9.6%, helped by volume growth and higher patient acuity.
- Labor efficiency improved, with RN turnover hitting a 12-year low of 19%.
- The repeal of North Carolina hospital limits opens a major new growth market for the company.
- Fears over the Review Choice Demonstration program eased after Texas claims saw a 98% affirmation rate.
Execution wins as fears fade
Encompass Health is showing clear operating momentum. In Q2 2026, net operating revenue increased 9.6% from the prior year, driven by a 5.6% growth in discharges. Management raised full-year guidance and increased the share repurchase authorization to $1 billion.
The strongest part of the story remains labor and expansion. Contract labor fell to just 1.1% of the workforce, and RN turnover dropped to 19%. Growth also received a clear boost when North Carolina repealed its Certificate of Need laws, allowing EHC to target 15 new markets in the state.
The primary risk has faded significantly. The Review Choice Demonstration is a Medicare review program that previously caused issues in Alabama. However, the recent rollout in Texas achieved an affirmation rate of over 98%, proving the company can handle the scrutiny.
Finn views the company favorably. EHC is executing well on labor, expanding its footprint, and clearing regulatory hurdles. The next proof points are scaling the strategy to fight Medicare Advantage denials and breaking ground in the new North Carolina markets.
Paid when patients leave rehab
Encompass Health makes money by treating patients in inpatient rehabilitation hospitals. These patients usually come from acute-care hospitals after events such as strokes, neurological problems, brain or spinal cord injuries, complex orthopedic conditions, or amputations.
Revenue is earned per discharge. Medicare is the primary payer, with Medicare Advantage, managed care, Medicaid, and others making up the rest. This payer mix gives EHC steady demand, but it also ties the business to government payment rules and insurance pre-authorization limits.
Growth comes from adding capacity. EHC builds new hospitals, called de novos, and adds beds to existing hospitals. Management uses prefabricated construction to improve speed-to-market for new hospitals by about 25%, helping new capacity start earning sooner.
The model breaks if claims are denied, nurses get scarce, or hospitals cannot fill new beds. The current focus is on fighting Medicare Advantage pre-authorization denials, a process that adds administrative costs and delays cash collection.
Rehab care, not broad hospitals
Stroke rehabilitation
Stroke is one of EHC’s most common patient types. These patients often need intensive therapy before they can safely go home.
Neurological rehabilitation
This includes complex neurological conditions that require coordinated care from nurses, therapists, and doctors. It supports the company’s core value of getting patients home and reducing readmissions.
Orthopedic and amputation rehabilitation
Patients recovering from complex orthopedic events or amputations may need inpatient rehab before daily life is possible again. This is a steady part of the IRF service mix.
Cardiac and pulmonary rehabilitation
Some patients recovering from heart or lung conditions need higher-intensity rehab than a nursing facility can provide. EHC serves them in dedicated hospital settings.
Brain and spinal cord injury rehabilitation
These cases can be complex and resource-heavy. They fit EHC’s focus on serious injuries that require coordinated inpatient care.
New hospitals and bed additions
Capacity expansion is the main growth engine. EHC builds de novo hospitals and adds beds where demand supports more inpatient rehab capacity.
One segment, mostly inpatient
EHC reports one operating and reportable segment: inpatient rehabilitation. The mix below uses Q1 2026 service-line revenue detail, where inpatient revenue was the vast majority of total operating revenue.
What could break the case
RCD claim reviews spread
Medium impact · Low oddsThe Review Choice Demonstration program is a Medicare review process. While Texas achieved a 98% affirmation rate, the program also applies to California and Alabama. Any failure to maintain high affirmation rates could delay cash collections and increase costs.
Medicare Advantage pressure rises
Medium impact · Medium oddsMedicare Advantage and managed care are important payers. If plans deny more referrals or push patients to cheaper settings, discharge growth can weaken. EHC is fighting these denials with an admit-and-appeal strategy that wins 89% of cases, but this adds administrative burden.
Labor savings reverse
Medium impact · Medium oddsEHC has improved labor efficiency, driving RN turnover to a 12-year low of 19%. However, hospitals still compete hard for nurses and therapists. The company expects near-term wage inflation as it invests in clinical career ladders to retain staff.
New capacity opens too slowly
Medium impact · Low oddsThe growth plan depends on opening new hospitals and adding beds, especially in the 15 targeted North Carolina markets. Projects can face delays, staffing limits, or weak local demand. If new beds do not fill, returns on capital fall.
Storms disrupt core markets
Medium impact · Medium oddsEHC has hospital concentration in the Southeast and Texas. Hurricanes and severe weather can disrupt staffing, patient admissions, utilities, and local hospital referrals. This remains a structural risk for the company.
In one breath
What does Encompass Health do?
Encompass Health runs inpatient rehabilitation hospitals. These hospitals help patients recover after major events like strokes, neurological conditions, injuries, amputations, and complex surgeries.
How does EHC make money?
EHC is paid mainly when patients are discharged from its rehab hospitals. Medicare is the largest payer, followed by Medicare Advantage, managed care, Medicaid, and other payers.
What is the biggest risk for EHC stock?
The biggest risk involves the Medicare Review Choice Demonstration program and Medicare Advantage pre-authorization denials. If more claims are delayed, denied, or appealed, cash flow could suffer.
Why did the thesis improve in Q2 2026?
The company beat expectations, raised guidance, and proved it could handle Medicare reviews in Texas with a 98% affirmation rate. The repeal of North Carolina hospital regulations also opened a new growth market.
